There are 594 resources available
296P - Circulating progastrin (hPG80): A versatile blood-based biomarker for all stages of non-small cell lung cancer management
Presenter: Eider Azkona
Session: Poster Display session
298P - Validation of the lung immune prognostic index (LIPI) in extensive-stage small cell lung cancer (esSCLC): Post hoc analysis of the CASPIAN and IMpower133 phase III trials
Presenter: Edouard Auclin
Session: Poster Display session
299P - First-line (1L) durvalumab (D) + platinum-etoposide (EP) in extensive-stage SCLC (ES-SCLC): Final results and exploratory biomarker analyses from LUMINANCE
Presenter: Natasha Leighl
Session: Poster Display session
300P - CT-based intratumoral and peritumoral radiometric characteristics accurately predict the risk of distant metastasis in small cell lung cancer
Presenter: Ran Wang
Session: Poster Display session
301P - Baseline CT radiomics predict response to chemotherapy and chemoimmunotherapy in extensive-stage small cell lung cancer (ES SCLC)
Presenter: Mohammadhadi Khorrami
Session: Poster Display session
302P - Phase II study of the efficacy and safety of BNT327/PM8002 plus systemic chemotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC)
Presenter: Ying Cheng
Session: Poster Display session
303P - Identifying novel prognostic markers in small cell lung cancer through comprehensive in-silico analysis
Presenter: Vivien Teglas
Session: Poster Display session
304P - Prognostic markers and molecular insights: Navigating SCLC with liver metastasis
Presenter: Jing Ding
Session: Poster Display session
305P - Liver metastases compromise the benefit of adding anti-PDL1 therapy to first-line chemotherapy in extensive-stage small cell lung cancer (esSCLC): A post hoc analysis of the CASPIAN and IMpower133 trials
Presenter: Edouard Auclin
Session: Poster Display session
306P - The effect of initial metastatic site on survival in extensive-stage small cell lung cancer
Presenter: Hatice Topal
Session: Poster Display session